CLINICAL COURSE OF HIV-ASSOCIATED TUBERCULOSIS IN THE PREGNANT WOMAN AND NEWBORN
https://doi.org/10.21292/2075-1230-2016-94-12-67-72
Abstract
The article describes the clinical case of TB/HIV coinfection in the pregnant woman and newborn. The discussion of the management tactics included main issues on which treatment success depended on: the right choice of chemotherapy regimen, correct decision on the time of delivery due to life-threatening conditions of the mother, timely diagnostics of tuberculosis in the newborn. It is necessary to develop cross-disciplinary guidelines by professional medical communities on the management of pregnant women with TB/HIV coinfection which will allow enhancing the quality of medical care to pregnant women and newborns at all stages of follow-up.
About the Authors
A. V. Nesterenko
Krasnoyarsk Clinical TB Dispensary no. 1
Russian Federation
Russian Federation
Deputy Head Doctor for Medical Activities,
26, 60 let Oktyabrya St., Krasnoyarsk, 660078
V. N. Zimina
People's Friendship University of Russia
Russian Federation
Russian Federation
Doctor of Medical Sciences, Associate Professor of Infectious Diseases Departments with Training Courses on Epidemiology and Tuberculosis Control of the Medical Institute,
2, Yauzskaya Alleya, Moscow, 107564
N. M. Koretskaya
V. F. Voyno-Yasenetsky State Medical University
Russian Federation
Russian Federation
Doctor of Medical Sciences, Professor of Tuberculosis Department,
1, Partizana Zheleznyaka St.,Krasnoyarsk, 660022
N. V. Kozyrina
Central Epidemiology Research Institute,
Rospotrebnadzor
Russian Federation
Russian Federation
Candidate of Medical Sciences, Researcher of Special Research Department of AIDS Epidemiology and Prevention,
15, Build. 2, 8 Sokolinaya Gora St., Moscow, 105275
References
1. Vasilieva I.А., Ergeshov А.E., Samoylova А.G. et al. Postponed outcomes of using standard chemotherapy regimens in respiratory tuberculosis patients. Tuberkulyoz i Bolezni Legkikh, 2012, no.4, pp.3-8. (In Russ.)
2. Zimina V.N., Batyrov F.А., Kravchenko А.V. et al. Profile of primary drug resistance in patients with respiratory tuberculosis with concurrent HIV infection. Tuberkulyoz i Bolezni Legkikh, 2011, no. 8, pp. 31-35. (In Russ.)
3. Ivashkin V.T., Yuschuk N.D., Maevskayam M.V., Znoyko O.O., Dudina K.R., Karetkina G.N., Klimova E.А., Maksimov S.L., Martynov Yu.V., Maev I.V., Pavlov Ch.S., Fedosina E.А., Bueverov А.O., Аbdurakhmanov D.T., Malyshev N.А., Nikitin N.G., Masyuk Ya.G., Lapina T.L., Trukhmanov А.S., Kozhevnikova G.M., Zhdanov K.V. , Rakhmanova А.G., Chulanov V.P., Shakhgildyan I.V., Syutkin V.E, Bogomolov P.O. Klinicheskie rekomendatsii Rossiyskoy gastroenterologicheskoy assotsiatsii i Rossiyskogo obschestva po izucheniyu pecheni po diagnostike i lecheniyu vzroslykh bolnykh gepatitom B. [Clinical guidelines by the Russian Gastroenterological Association and Russian Society on Liver Studies on diagnostics and treatment of adults suffering from hepatitis B]. 3, 2014, pp.82-85.
4. Panteleev A.M. Bacillary excretion and drug resistance in case of tuberculosis in HIV patients in St.Petersburg. VICH-Infektsiya i Immunosuprssiya, 2011, no. 2, pp. 57-62. (In Russ.)
5. Edict no. 892 as of 25.12.2001 by RF Government On the Implementation of the Federal Law On Tuberculosis Transmission Prevention in the Russian Federation. (Collection of the Russian Laws, 2001, no. 53 (2.2), pp. 5185). (In Russ.)
6. Edict no. 109 by RF MoH as of 21.03.2003 On Improvement of TB Control Measures in the Russian Federation. 347 p. (In Russ.)
7. Edict no. 951 by RF MoH as of 29.12.2014 On Approval of Guidelines for Improvement of Respiratory Tuberculosis Diagnostics and Treatment. 19 p. (In Russ.)
8. Samoylova А.G., Vasilieva I.А., Ivanov А.K., Galkin V.B., Maryandyshev А.O., Yablonsky P.K. Efficiency of standard chemotherapy regimens for treatment of tuberculosis depending on the susceptibility pattern of mycobacteria. Tuberkulyoz i Bolezni Legkikh, 2012, no.4, pp.23-29. (In Russ.)
9. Tsinzerling V.А., Krasnogorskaya O.L., Vasilieva M.V. et al. Perinatal pathology in HIV infection. Arkhiv Patologii, 2005, no. 5, vol. 67, pp. 48-51. (In Russ.)
10. Arbex M.A., Varella M.C.L., Siqueira H.R. et al. Antituberculosis drugs: drug interactions, adverse effects, and use in special situations. Part 2: second-line drugs. J. Bras. Pneumol., 2010, no. 36 (5), pp. 641-656.
11. Lee L.H., LeVea C.M., Graman P.S. Congenital Tuberculosis in a neonatal intensive care unit: case report, epidemiological investigation, and management of exposures. CID, 1998, no. 27, pp. 474-477. (In Russ.)
12. Özcan B., Ener Ç.D., Kadir K. et al. Congenital tuberculosis with multisystem involvement: a case report. Turkish Respiratory Journal, 2007, no. 8(1), pp. 36-38.
13. Khan M., Pillay T., Moodley J.M. Maternal mortality associated with tuberculosis-HIV-1 co-infection in Durban, South Africa. AIDS, 2001, no. 15, pp. 1857-1863.
14. Ribeiro P.S., Jacobsen K.H., Mathers C.D. et al. Priorities for women's health from the global burden of disease study.. Int. J. Gynaecol. Obstet., 2008, no. 102(1), pp. 82-90.
15. Snider D., Bloch A. Congenital tuberculosis. Tubercle, 1984, no. 65, pp. 81-82.
16. Starke J.R. An old disease but a new threat to the mother, fetus, and neonate. Clin. Perinatol., 1997, no. 24, pp. 107-127.
17. Wang S.L., Coonley F. Occurrence of tubercle bacilli in breast milk of tuberculous women. JAMA, 1917, no. 69, pp. 531-532.
Review
For citations:
Nesterenko A.V., Zimina V.N., Koretskaya N.M., Kozyrina N.V. CLINICAL COURSE OF HIV-ASSOCIATED TUBERCULOSIS IN THE PREGNANT WOMAN AND NEWBORN. Tuberculosis and Lung Diseases. 2016;94(12):67-72. (In Russ.) https://doi.org/10.21292/2075-1230-2016-94-12-67-72
Views:
1129
Email this article 